Efficacy and safety of cimicoxib in the control of perioperative pain in dogs
Objectives To determine the efficacy and safety of cimicoxib (Cimalgex®; Vétoquinol SA) for the control of perioperative pain in dogs. Methods A double‐blind, randomized, controlled multi‐centre field study was conducted in 237 dogs undergoing orthopaedic or soft tissue surgery. Pain was monitored b...
Saved in:
Published in | Journal of small animal practice Vol. 54; no. 6; pp. 304 - 312 |
---|---|
Main Authors | , , |
Format | Journal Article |
Language | English |
Published |
Oxford, UK
Blackwell Publishing Ltd
01.06.2013
Wiley Subscription Services, Inc |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Objectives
To determine the efficacy and safety of cimicoxib (Cimalgex®; Vétoquinol SA) for the control of perioperative pain in dogs.
Methods
A double‐blind, randomized, controlled multi‐centre field study was conducted in 237 dogs undergoing orthopaedic or soft tissue surgery. Pain was monitored by the attending veterinarian over the 7 days following the surgical procedure using two pain‐scoring systems and a visual analogue scale. An enhanced monitoring protocol for postoperative pain was utilized during the first 24 hours after surgery. The dog owner's assessment of perceived analgesia during this time period was also recorded.
Results
Cimicoxib demonstrated statistically significant non‐inferiority compared to carprofen. These findings were confirmed by owners’ assessments and by the evolution of the pain scores. Both drugs were well tolerated throughout the study.
Clinical Significance
Cimicoxib had non‐inferior efficacy and tolerability when compared to carprofen for the control of perioperative pain in dogs undergoing orthopaedic or soft tissue surgery. |
---|---|
Bibliography: | ArticleID:JSAP12082 istex:34A177EC0E5C1F97EEF57914630090F01B159251 ark:/67375/WNG-XW1CQTKX-B ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-News-2 ObjectType-Feature-3 content type line 23 |
ISSN: | 0022-4510 1748-5827 |
DOI: | 10.1111/jsap.12082 |